Candy Samples’ Powers for Good Shannon Stephenson/Cempa Community Care
Being a southern gal residing in NYC, I always find a soft spot for a fellow southerner——someone that “gets” sweet tea and some good cornbread. And growing up in Atlanta…
Fighting to Preserve the Benefits of the 340B Program
Being a southern gal residing in NYC, I always find a soft spot for a fellow southerner——someone that “gets” sweet tea and some good cornbread. And growing up in Atlanta…
“We are taking the fight to the states,” said Shannon Stephenson, president of Ryan White Clinics for 340B Access (RWC-340B), a national organization of HIV/AIDS medical providers receiving support under…
Powers drafted the attached template COVID-19 Policies and Procedures that incorporate HRSA/OPA’s relaxed guidance to help 340B covered entities address the coronavirus pandemic. We hope that you find these Policies…
On April 2, the Food and Drug Administration (FDA) announced that, effective immediately, it is modifying its current policy to shorten the abstinence period, from 12 months to 3 months,…
In our continuing efforts to provide you with relevant and timely information during the COVID-19 crisis, Powers has set up a dedicated webpage for information on COVID-19. We provide below…
The Centers for Medicare & Medicaid Services (CMS) released a toolkit on Medicare payments to providers of telehealth and telemedicine services on Friday, March 20. The toolkits give further information…
HRSA/OPA Guidance in Response to COVID-19 Late yesterday, HRSA/OPA updated its website to include guidance addressing the COVID-19 pandemic. The guidance states: Case-by-Case Waivers – OPA is reviewing on a…
The COVID-19 pandemic has created an increased need for the use of telehealth services. Powers has received several questions from Ryan White clinics about whether a prescription for a patient…
On February 10, 2020, the White House released the Administration’s budget proposal for Fiscal Year (FY) 2021, A Budget For America’s Future. This document summarizes the President’s recommendations for funding…
On January 28, 2020, HRSA posted results of its 340B Program audit of four pharmaceutical manufacturers in fiscal year 2019. Three of the four audited manufacturers were found to have…